follica patent allowance. news or just stock-hyping?

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lacazette
    Senior Member
    • May 2015
    • 394

    #31
    Sarah millar was saying in one of her study that the missing key to be successful was the first event pathway occuring during skin regeneration, and that it wasn't uncovered yet

    this very first event pathway is TLR3 discovery, as explained by luis Garza study from this summer

    Differents chemicals TLR3 agonists are already available, so just a matter of time for them to test it with their protocol ( we could ask follica's team about TLR3 discovery impact)

    I really think they will surprise us soon, Cotsarelis and Millar dedicated their life to the hair follicle, more than 20 years of working with also in their mind the project to find a cure. They know how researchers are now able to grow hair with iPSCs and 3D printing/bioengineering, and how those areas are growing insanely, so if they want to success, make billions and mark history with their wounding neogenesis approach, they have to hit the market asap, and before all of them :
    Regience, Sisheido, TsujiLab, Keio hair regeneration, Sung jan lin/taiwanbioengineering, Terskish/S&B, Thangapazham/USarmy, Protect&Gambler/Singapore,Cheng-Ming Chuong LAB, Sriwiriyanont/Kimberly-Clark, Chung‑Ang University/Korea, Jahoda/Higgins/Cristiano, the ones that I miss or that we don't know, and a few ones from china and europe, that's a hell of competitors. And Im sure Cotsarelis wants to be the hairloss hero

    Comment

    Working...